Molecular Partners AG MOLN
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -100.00% | -91.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -100.00% | -91.14% |
| Cost of Revenue | -9.47% | -10.52% | -13.04% | -16.26% | -13.35% |
| Gross Profit | 8.01% | 5.91% | 2.89% | 4.83% | -0.96% |
| SG&A Expenses | -2.25% | -3.51% | -7.43% | -7.07% | -3.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.34% | -8.49% | -11.45% | -13.72% | -10.78% |
| Operating Income | 6.29% | 5.19% | 4.28% | 5.51% | 0.56% |
| Income Before Tax | 14.08% | -7.50% | -20.57% | -0.05% | -15.74% |
| Income Tax Expenses | 4,900.00% | 4,900.00% | 21.74% | -- | -- |
| Earnings from Continuing Operations | 14.08% | -7.51% | -20.57% | -0.05% | -15.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.08% | -7.51% | -20.57% | -0.05% | -15.74% |
| EBIT | 6.29% | 5.19% | 4.28% | 5.51% | 0.56% |
| EBITDA | 6.41% | 5.37% | 4.28% | 5.58% | 0.49% |
| EPS Basic | 17.81% | -0.03% | -9.43% | 11.10% | -5.80% |
| Normalized Basic EPS | 14.44% | 4.50% | -4.62% | 15.23% | -1.50% |
| EPS Diluted | 17.89% | 0.08% | -9.30% | 11.00% | -5.91% |
| Normalized Diluted EPS | 14.44% | 4.50% | -4.62% | 15.23% | -1.50% |
| Average Basic Shares Outstanding | 4.35% | 6.83% | 9.51% | 12.45% | 9.57% |
| Average Diluted Shares Outstanding | 4.35% | 6.83% | 9.51% | 12.45% | 9.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |